A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : AL / amyloid light-chain

[Related PubMed/MEDLINE]
Total Number of Papers: 187
[Display Entries]
100 entries :
     (Publication year, Descending)
100 entries :
     (Publication year, Ascending)
>> all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   AL  (>> Co-occurring Abbreviation)
Long Form:   amyloid light-chain
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2020 A case of AL amyloidosis associated with follicular lymphoma with plasmacytic differentiation. FISH, FL
2020 Autonomic dysfunction in cardiac amyloidosis assessed by heart rate variability and heart rate turbulence. AS, CA, HF, HRT, HRV, LVH
2020 Genomic profiling in amyloid light-chain amyloidosis reveals mutation profiles associated with overall survival. OS, PCs, SMGs, TGS
2020 Progressive multifocal leukoencephalopathy in a patient with primary amyloid light-chain amyloidosis. auto-PBSCT, PML
2020 Use of ixazomib, lenalidomide and dexamethasone in patients with relapsed amyloid light-chain amyloidosis. CR, PFS, PR, VGPR
2019 A Substantial Structural Conversion of the Native Monomer Leads to in-Register Parallel Amyloid Fibril Formation in Light-Chain Amyloidosis. ---
2019 Autologous Stem Cell Transplant for IgM-Associated Amyloid Light-Chain Amyloidosis. ASCT, OS, PFS
2019 Bortezomib-based chemotherapy reduces early mortality and improves outcomes in patients with ultra-high-risk light-chain amyloidosis: a retrospective case control study. OS, PFS
2019 Breast MALT lymphoma and AL amyloidosis complicating Sjogren's syndrome. MALT
10  2019 Cardiac amyloidosis: the need for early diagnosis. ATTRm, TTR
11  2019 Chronic intestinal pseudo-obstruction due to al amyloidosis: a case report and literature review. CIPO
12  2019 Cutaneous light chain amyloidosis with multiple myeloma: A concise review. Ig, MM
13  2019 Cyclophosphamide+ Thalidomide+ Dexamethasone Versus Melphalan+ Dexamethasone for the Treatment of Amyloid Light-chain Amyloidosis With Kidney Involvement: A Retrospective Study in Chinese Patients. CTD, MD
14  2019 Estimating the Prevalence of Transthyretin Amyloid Cardiomyopathy in a Large In-Hospital Database in Japan. MDV, TTR
15  2019 Identification of Candidate Genes and Therapeutic Agents for Light Chain Amyloidosis Based on Bioinformatics Approach. DEGs, PPI
16  2019 Improvement of global longitudinal strain following high-dose chemotherapy and autologous peripheral blood stem cell transplantation in patients with amyloid light-chain cardiac amyloidosis: a case report. auto-PBSCT, CA, GLS
17  2019 Kidney embolization induces prompt organ response in a 86-year-old patient with MGRS-related AL-amyloidosis. MGRS
18  2019 Lower respiratory tract amyloidosis: Presentation, survival and prognostic factors. A multicenter consecutive case series. HR, LRT
19  2019 MAGE genes: Prognostic indicators in AL amyloidosis patients. MM
20  2019 Multiorgan involvement by amyloid light chain amyloidosis. ---
21  2019 Outcomes of Patients with Light Chain Amyloidosis Who Had Autologous Stem Cell Transplantation with 3 or More Organs Involved. ASCT, NT-proBNP, OS, PFS, RR
22  2019 Perianal purpuric plaques revealing an amyloid light-chain amyloidosis: case report and review of the literature. ---
23  2019 Prevalence and clinical implications of t(11;14) in patients with amyloid light-chain amyloidosis with or without concurrent multiple myeloma. MM
24  2019 Primary cervical spine AL-kappa amyloidoma: A case report and review of the literature. ---
25  2019 Silver Nanoparticle-Based Assay for the Detection of Immunoglobulin Free Light Chains. DLS, FLCs, MM, MNP
26  2019 Splenic rupture secondary to amyloid light-chain (AL) amyloidosis associated with multiple myeloma. ---
27  2019 Symptomatic involvement of the stomach and duodenum as initial presentation of AL amyloidosis. ---
28  2019 Untangling the clinical and economic burden of hospitalization for cardiac amyloidosis in the United States. ---
29  2019 Utility of B-Type Natriuretic Peptide for Detecting Cardiac Involvement in Immunoglobulin Amyloidosis. BNP, CA, dFLC, hs-cTnT
30  2019 Zebrafish model of amyloid light chain cardiotoxicity: regeneration versus degeneration. LC
31  2019 [A systemic disease mimicking a rheumatoid arthritis]. MGUS
32  2019 [Right Atrium Thrombus Due to Cardiac Amyloidosis;Report of a Case]. CT
33  2018 'Transformation' from amyloid light chain amyloidosis to symptomatic multiple myeloma. MM
34  2018 Amyloid Proximal Tubulopathy and Amyloid Casts: An Unusual Finding in Multiple Myeloma. MM
35  2018 Clinical and endoscopic manifestations of gastrointestinal amyloidosis: a case series. GI
36  2018 Clinical and laboratory profile of renal amyloidosis: A single-center experience. AA, TB
37  2018 Diagnosis and Management of a Cardiac Amyloidosis Case Mimicking Hypertrophic Cardiomyopathy. LVOT
38  2018 Epidemiology of AL amyloidosis: a real-world study using US claims data. APC
39  2018 Healthcare resource utilization and costs in amyloid light-chain amyloidosis: a real-world study using US claims data. ---
40  2018 Incidentally Detected Amyloid Light-Chain Amyloidosis Caused by Monoclonal Gammopathy of Undetermined Significance: Possible Time-Dependent Change in Colonic Findings. MGUS
41  2018 Intramyocardial inflammation predicts adverse outcome in patients with cardiac AL amyloidosis. ATTR, EMB
42  2018 Light Chain Amyloidosis Presenting as Bilateral External Auditory Canal Obstructing Masses. ---
43  2018 MR neurography biomarkers to characterize peripheral neuropathy in AL amyloidosis. MRN, PNP
44  2018 Nationwide Survey of 741 Patients with Systemic Amyloid Light-chain Amyloidosis in Japan. ASCTs, GI
45  2018 Rare Undiagnosed Primary Amyloidosis Unmasked During Surgical Treatment of Primary Hyperparathyroidism: A Case Report. PA, PA, PHPT
46  2018 The Long-term Outcomes after VAD plus SCT Therapy in a Patient with AL Amyloidosis and Severe Factor X Deficiency. BJP
47  2018 Trifascicular block as primary presentation of the cardiac amyloidosis; A rare case report. ---
48  2018 [Heart transplantation in AL amyloidosis]. ASCT
49  2017 A case of primary amyloidosis with spontaneous hepatic rupture. ---
50  2017 A Novel Method of DAPI Staining for Differential Diagnosis of Renal Amyloidosis. AA, DAPI
51  2017 Addition of cyclophosphamide and higher doses of dexamethasone do not improve outcomes of patients with AL amyloidosis treated with bortezomib. ---
52  2017 AL amyloidosis patients with low amyloidogenic free light chain levels at first diagnosis have an excellent prognosis. dFLC, HR
53  2017 Case report: One case of primary AL amyloidosis repeatedly misdiagnosed as scleroderma. ---
54  2017 Clinical Presentation of Tubulointerstitial Nephritis Caused by Amyloid Light-chain Amyloidosis in a Patient with Sjogren's Syndrome. ---
55  2017 Contribution of human smooth muscle cells to amyloid angiopathy in AL (light-chain) amyloidosis. LCs, SMCs, VSMCs
56  2017 Diagnosing Light Chain Amyloidosis on Temporal Artery Biopsies for Suspected Giant Cell Arteritis. ---
57  2017 Diffuse Peritoneal and Bowel Wall Infiltration by Light Chain-AL Amyloidosis with Omental Calcification Mimicking Abdominal Carcinomatosis - An Elderly Female with Incidental Finding of Light Chain Monoclonal Gammopathy of Undetermined Significance (LC-MGUS). AA, CT, GIT, Ig, LC-MGUS, LC-MGUS, MGUS
58  2017 Heat-induced native dimerization prevents amyloid formation by variable domain from immunoglobulin light-chain REI. LCs, VL
59  2017 Light chain amyloidosis: Where are the light chains from and how they play their pathogenic role? ---
60  2017 Light-chain cardiac amyloidosis: strategies to promote early diagnosis and cardiac response. LC
61  2017 Localized Immunoglobulin Light Chain Amyloid of the Conjunctiva Confirmed by Mass Spectrometry Without Evidence of Systemic Disease. ---
62  2017 Long-term event-free and overall survival after risk-adapted melphalan and SCT for systemic light chain amyloidosis. CI, CR, EFS, OS, SCT, TRM
63  2017 Long-term prognosis of AL and AA renal amyloidosis: a Japanese single-center experience. AA
64  2017 Lung adenocarcinoma expressing receptor for advanced glycation end-products with primary systemic AL amyloidosis: a case report and literature review. NSCLC, RAGE
65  2017 Measurement of liver and spleen interstitial volume in patients with systemic amyloid light-chain amyloidosis using equilibrium contrast CT. ECV, EQ-CT, SAP
66  2017 Mutational landscape reflects the biological continuum of plasma cell dyscrasias. CI, MGUS, NGS, OR
67  2017 Proteasome inhibitors in AL amyloidosis: focus on mechanism of action and clinical activity. ---
68  2017 The Lung in Dysregulated States of Humoral Immunity. ---
69  2017 The prognostic value of multiparametric flow cytometry in AL amyloidosis at diagnosis and at the end of first-line treatment. EOT, MFC, OS, PCs, PFS
70  2017 The treatment of paraprotein-related kidney disease. ---
71  2016 2A4 binds soluble and insoluble light chain aggregates from AL amyloidosis patients and promotes clearance of amyloid deposits by phagocytosis †. LC
72  2016 A Case of Abdominal Aortic Retroperitoneal and Mesenteric Amyloid Light Chain Amyloidoma. ---
73  2016 A case of isolated amyloid light-chain amyloidosis of the radial nerve. MRN
74  2016 Amyloid Light-Chain Amyloidosis Manifesting as Heart Failure with Preserved Ejection Fraction in a Patient with Hyper-Immunoglobulin E-emia. HFpEF, LV
75  2016 Anxiety and depression among amyloid light-chain cardiac amyloidosis patients: The role of life satisfaction. ---
76  2016 Bortezomib-Containing Regimens for the Treatment of Newly Diagnosed and Relapsed Amyloid Light Chain Amyloidosis: A Single-Center Experience. NT-proBNP
77  2016 Cardiac Amyloid Load: A Prognostic and Predictive Biomarker in Patients With Light-Chain Amyloidosis. ATTR, NYHA
78  2016 Clinical and prognostic significance of serum levels of von Willebrand factor and ADAMTS-13 antigens in AL amyloidosis. NT-proBNP, SBP, vWF
79  2016 Clinical Characteristics and Treatment Outcome of Chinese Patients With Systemic Amyloid Light-Chain Amyloidosis: A Retrospective Single-Center Analysis. OS
80  2016 Correlation of histomorphological pattern of cardiac amyloid deposition with amyloid type: a histological and proteomic analysis of 108 cases. AA, OR
81  2016 Flow cytometry-based characterization of underlying clonal B and plasma cells in patients with light chain amyloidosis. MFC, PC
82  2016 Higher Stem Cell Dose Infusion after Intensive Chemotherapy Does Not Improve Symptom Burden in Older Patients with Multiple Myeloma and Amyloidosis. ASCT, MM
83  2016 Immunoglobulin Light-Chain Amyloidosis: From Basics to New Developments in Diagnosis, Prognosis and Therapy. ---
84  2016 LGE Provides Incremental Prognostic Information OverSerum Biomarkers in ALCardiacAmyloidosis. CMR, LGE, TI
85  2016 Oral purpura as the first manifestation of primary systemic amyloidosis. ---
86  2016 Plasma hepatocyte growth factor is a novel marker of AL cardiac amyloidosis. gal-3, HGF, IL-6, IQR, LVH, VEGF
87  2016 Recurrent mutations of MAPK pathway genes in multiple myeloma but not in amyloid light-chain amyloidosis. MAPK
88  2016 Regional myocardial microvascular dysfunction in cardiac amyloid light-chain amyloidosis: assessment with 3T cardiovascular magnetic resonance. CMR, LV, LVEF, MaxSI, TTM
89  2016 Successful Treatment of Amyloid Light-chain Amyloidosis in a Charcot-Marie-Tooth Disease Patient with Lenalidomide, Cyclophosphamide, and Dexamethasone. CMT
90  2015 A practical approach to the diagnosis of systemic amyloidoses. IEM
91  2015 AL Amyloidosis Complicated by Persistent Oral Bleeding. ---
92  2015 Atypical case of AL amyloidosis with urinary erythrocyte casts. ---
93  2015 Bilateral kidney infarction due to primary Al amyloidosis: a first case report. ---
94  2015 Clinical presentation and treatment responses in IgM-related AL amyloidosis. HDM/SCT
95  2015 Differential effects on light chain amyloid formation depend on mutations and type of glycosaminoglycans. ---
96  2015 Hereditary systemic immunoglobulin light-chain amyloidosis. ---
97  2015 Malnutrition, pharmaconutrition and other considerations in AL amyloidosis, a rare disease with masquerading symptoms and usually delayed diagnosis. ---
98  2015 Myopathy in a patient with systemic AA amyloidosis possibly induced by psoriasis vulgaris: An autopsy case. AA
99  2015 T1 mapping and survival in systemic light-chain amyloidosis. CI, CMR, ECV, HR
100  2015 The myocardial contraction fraction is superior to ejection fraction in predicting survival in patients with AL cardiac amyloidosis. EF, MCF, MV, SV